Ixoberogene Soroparvovec (Ixo-vec) IVT Gene Therapy for Neovascular AMD: Phase 2 LUNA Study Update

Related

• 

  Pradeepa Yoganathan Last Word

  Pradeepa Yoganathan, MSc, MD, FRCS(C)

  Annual Meeting Talks

• 

  Intravitreal Gene Therapy for Diabetic Macular Edema With ADVM-022: First-Time Data Presentation of Prospective, Randomized Phase 2 INFINITY Trial

  Charles C Wykoff, MD, PhD, FASRS

  Annual Meeting Talks

  2021

• 

  Expert Panel: AI

  Mark S. Humayun, MD, PhD

  Devinder S Chauhan, MD FRCOphth FRANZCO

  Ursula M. Schmidt-Erfurth, MD

  Jennifer I. Lim, MD, FARVO, FASRS

  Royce WS Chen, MD

  Annual Meeting Talks

  2024